SCHEMBL4769744

SCHEMBL4769744

CCCCOC(=O)NCCc1ccc(O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.57
GLA P06280 1/20 0.57
ACHE P22303 12/20 0.56
KDM4E B2RXH2 1/20 0.55
F13A1 P00488 1/20 0.55
CNR2 P34972 2/20 0.54
LMNA P02545 1/20 0.53
ESR1 P03372 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
TSHR P16473 1/20 0.53
MAPK1 P28482 1/20 0.53
CYP2C19 P33261 1/20 0.53
NR1H2 P55055 1/20 0.53
RNASEL Q05823 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7201386 0.94 CNR2 (0.58) KMT2AGLAACHEKDM4EF13A1
SCHEMBL8554270 0.93 ACHE (0.58) ACHEKDM4ELMNAESR1CYP1A2
SCHEMBL21382248 0.88 KMT2A (0.57) KMT2AGLAACHEHDAC3HDAC4
SCHEMBL8585756 0.87 KMT2A (0.56) KMT2AGLAACHEHDAC3HDAC4
SCHEMBL5110887 0.87 NPC1 (0.63) KMT2AGLAACHELMNASMN1; SMN2
SCHEMBL8621504 0.86 ACHE (0.59) ACHEKDM4ELMNAESR1
SCHEMBL7200875 0.86 ACHE (0.59) ACHEKDM4ELMNAESR1
SCHEMBL8624782 0.86 ACHE (0.57) ACHEKDM4ECNR2LMNAESR1
SCHEMBL27887140 0.86 KMT2A (0.55) KMT2AGLAACHESMN1; SMN2HDAC3
SCHEMBL8590341 0.85 CYP1A2 (0.55) ACHECNR2LMNAESR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 EP disclosed
EP-1311625-B1 FUNCTIONALIZED PERYLENE TETRACARBOXYLIC ACID DIIMIDES MAX PLANCK GESELLSCHAFT (DE) 2006-02-01 EP disclosed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 EP disclosed
US-6916928-B2 Functionalized perylene tetracarboxylic acid diimides MAX-PLANCK-GESELLSCHAFT DER WISSENSCHAFTENE.V. (DE) 2005-07-12 US disclosed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 WO disclosed
US-20040024151-A1 Functionalized perylene tetracarboxylic acid diimides MAX-PLANCK-GESELLSCHAFT DER WISSENSCHAFTENE. V. (DE) 2004-02-05 US disclosed
CN-1374955-A Oxazole and thiazole derivatives as antidiabetic and antiobesity agents BRISTOL MYERS SQUIBB CO (US) 2002-10-16 CN disclosed
EP-0869949-A1 BENZOXAZINE ANTIMICROBIAL AGENTS ORTHO PHARMACEUTICAL CORPORATION (US) 1998-10-14 EP disclosed
WO-1997017333-A1 BENZOXAZINE ANTIMICROBIAL AGENTS ORTHO PHARMACEUTICAL CORPORATION (US) 1997-05-15 WO disclosed
US-4818766-A ANTIARRHYTHMIA AGENTS, HYPOTENSIVE AGENTS, TREATMENT OF ANGINA CIBA-GEIGY CORPORATION (US) 1989-04-04 US disclosed